Bibliografía

1. Nam JL, Takase-Minegishi K, Ramiro S, Chatzidionysiou K, Smolen JS, Van der Heijde D, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2017; 76(6): 1.113-1.136.

2. Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, et al. Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev. 2011; 27: CD008794.

3. Kalden JR. Emerging therapies for rheumatoid arthritis. Rheumatol Ther. 2016; 3: 31-42.

4. Tracy A, Buckley CD, Raza K. Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start? Semin Immunopathol. 2017; 39(4): 423-435.